Tamiron, 0.4 mg, prolonged-release hard capsules
Tamsulosin hydrochloride
The active substance of Tamiron is tamsulosin hydrochloride, which belongs to the group of selective alpha-1A/1D adrenergic receptor antagonists. It reduces the tension of the smooth muscles of the prostate and urethra, making it easier for urine to flow through the urethra and facilitating urination. Additionally, it reduces the feeling of pressure on the bladder. Tamiron is used in men to treat symptoms of benign prostatic hyperplasia (enlargement of the prostate gland). These symptoms may include difficulty urinating (weak urine flow), urinating in drops, pressure on the bladder, and the need to urinate frequently at night and during the day.
Before starting to take Tamiron, discuss it with your doctor or pharmacist.
The medicine should not be given to children or adolescents under 18 years of age, as it has no effect in this patient group.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take. This is necessary because Tamiron may affect the way some other medicines work, and some other medicines may affect the way Tamiron works. In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
The medicine should be taken after the first meal of the day. Taking the medicine on an empty stomach may increase the number and severity of side effects.
Tamiron is not indicated for use in women. In short- and long-term clinical trials, tamsulosin has been associated with ejaculation disorders. After the marketing of the medicine, cases of ejaculation disorder, retrograde ejaculation, and absence of ejaculation have been reported.
There are no data on the effects of tamsulosin on the ability to drive or use machines. However, you should be aware of the possibility of dizziness. In this case, do not perform tasks that require attention.
The medicine contains less than 1 mmol (23 mg) of sodium per capsule, which means the medicine is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Your doctor has prescribed a dose tailored to you and your condition, also determining the duration of treatment. Do not change the prescribed dose without consulting your doctor first. If you feel that the effect of Tamiron is too strong or too weak, you should consult your doctor or pharmacist.
Taking too many Tamiron capsules may cause unwanted low blood pressure and increased heart rate with a feeling of fainting. If you have taken too much Tamiron, contact your doctor immediately.
If you miss a dose of Tamiron at the recommended time, you can take it later that day. If you forget to take the medicine on a given day, you should take the next capsule at the usual time the next day. Do not take a double dose to make up for the missed dose.
If you stop taking Tamiron prematurely, the symptoms of the disease may return. Therefore, you should take Tamiron for the period prescribed by your doctor, even after the symptoms have disappeared. Before stopping the medicine, you should always consult your doctor. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Tamiron can cause side effects, although not everybody gets them. Stop taking the medicine and contact your doctor immediatelyif you experience any of the following serious side effects:
Other side effects include:
Common (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1,000 patients)
Very rare (may affect up to 1 in 10,000 patients)
Frequency not known (frequency cannot be estimated from the available data)
If you need to undergo eye surgery due to cataracts or increased eye pressure (glaucoma) and are taking or have recently taken Tamiron, there may be a problem with dilating the pupil, and the iris may become floppy during the procedure.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Adverse Reactions to Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children. There are no special storage instructions for the medicine. Store in the original packaging to protect from moisture. Do not use this medicine after the expiry date stated on the carton, label, or blister. The expiry date refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Prolonged-release hard capsule. The hard gelatin capsule consists of two parts: a non-transparent olive-green and a non-transparent orange part, with a black edible ink print in the form of the letter "D" on the outer part and the number "53" on the inner part. The capsules contain white or off-white pellets. The length of the capsule is 20.4 mm. Pack sizes: Blister: 10, 14, 20, 28, 30, 50, 56, 60, 90, 98, 100, 200, and 250 capsules. Container: 10 and 250 capsules. Not all pack sizes may be marketed.
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Date of last revision of the leaflet:17.02.2021
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.